Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib-II Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. A Study of the Dutch Head and Neck Society

NCT02054442 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02054442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib-II Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. A Study of the Dutch Head and Neck Society
Lead sponsor
Radboud University Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2016
Completion date
December 31, 2022
Enrollment
52 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck